CORE--MONOCLONAL ANTIBODIES

$291,807P01FY2002CANIH

Whitehead Institute For Biomedical Res, Cambridge MA

Investigators

Linked publications & trials

Paper 34703030 Paper 34112789 Paper 33997789 Paper 33536619 Paper 33328216 Paper 33158843 Paper 33158842 Paper 32939090 Paper 32416067 Paper 32249764 Paper 32049041 Paper 31932421 Paper 31519911 Paper 31375632 Paper 31251913 Paper 31110002 Paper 31063750 Paper 30893315 Paper 30753830 Paper 30472020 Paper 30380416 Paper 30254159 Paper 29987050 Paper 29438694 Paper 29351847 Paper 29212856 Paper 29160310 Paper 29099267 Paper 28933153 Paper 28811299 Paper 28666979 Paper 28607489 Paper 28428275 Paper 28399412 Paper 28397828 Paper 28273452 Paper 28270621 Paper 28242709 Paper 28192421 Paper 28057845 Paper 27791031 Paper 27530323 Paper 27373334 Paper 27237051 Paper 27072748 Paper 27033256 Paper 26977878 Paper 26965145 Paper 26941287 Paper 26735014 Paper 26437589 Paper 26331542 Paper 25699710 Paper 25619437 Paper 25583800 Paper 25486477 Paper 25400221 Paper 25388283 Paper 25266422 Paper 25252691 Paper 25184681 Paper 25092866 Paper 25082194 Paper 24937458 Paper 24802759 Paper 24630040 Paper 24398047 Paper 24220145 Paper 24202396 Paper 24142877 Paper 24035453 Paper 24029232 Paper 23770079 Paper 23764000 Paper 23741308 Paper 23657012 Paper 23530127 Paper 23255249 Paper 23220226 Paper 23092187 Paper 23079664 Paper 23079655 Paper 23077249 Paper 22915759 Paper 22843421 Paper 22704558 Paper 22609699 Paper 22513401 Paper 22385965 Paper 22318515 Paper 22000009 Paper 21741601 Paper 21654808 Paper 21533021 Paper 21336303 Paper 21041659 Paper 20956832 Paper 20956553 Paper 20889718 Paper 20591988

Abstract

DESCRIPTION: (Applicant's Description) This core will provide monoclonal antibody production for members of this Program grant. The overall goal of this Program is to elucidate the functional roles of a number of key proteins that participate in breast development and breast carcinogenesis. High quality antibodies are essential reagents needed to study these proteins. We have developed a productive and highly efficient core for the production of monoclonal antibodies, and this core will provide this service for the participating investigators of this Program grant. The resulting antibodies will be available to members of this Program grant and through them to the research community as a whole.

View original record on NIH RePORTER →